Estimation of the infectious viral load required for transfusion-transmitted human T-lymphotropic virus type 1 infection (TT-HTLV-1) and of the effectiveness of leukocyte reduction in preventing TT-HTLV-1

Vox Sanguinis

Volumn 109, Issue 2, 2015, Pages 122-128

  Sobata, R ^a   Matsumoto, C ^a   Uchida, S ^a   Suzuki, Y ^b   Satake, M ^a   Tadokoro, K ^a  

^a SUWA RED CROSS HOSPITAL   (Japan)

^b Japanese Red Cross Kanto Koshinetsu Block Blood Center   (Japan)

Author keywords

HTLV 1; Leucocyte reduction; Proviral load; Transfusion; Transfusion transmitted infection

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; FEMALE; HUMAN; INFECTION PREVENTION; LEUKAPHERESIS; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; THERAPY EFFECT; TRANSFUSION TRANSMITTED HUMAN T LYMPHOTROPIC VIRUS TYPE 1 INFECTION; VIRUS INFECTION; VIRUS LOAD; ADVERSE EFFECTS; BLOOD; BLOOD TRANSFUSION; EVALUATION STUDY; GENETICS; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOGENICITY; TRANSMISSION;

VIRUS DNA;

ADOLESCENT; ADULT; BLOOD TRANSFUSION; DNA, VIRAL; FEMALE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; MALE; MIDDLE AGED; VIRAL LOAD;

EID: 84937073744     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12263     Document Type: Article

References (48)

1. Uchiyama T, Yodoi J, Sagawa K, et al.: Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977; 50:481-492
2. Osame M, Usuku K, Izumo S, et al.: HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; 327:1031-1032
3. Nicot C: Current views in HTLV-I-associated adult T-cell leukemia/lymphoma. Am J Hematol 2005; 78:232-239
4. de Thé G, Bomford R: An HTLV-I vaccine: why, how, for whom? AIDS Res Hum Retroviruses 1993; 9:381-386
5. Satake M, Yamaguchi K, Tadokoro K: Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. J Med Virol 2012; 84:327-335
6. Yamaguchi K, Watanabe T: Human T lymphotropic virus type-I and adult T-cell leukemia in Japan. Int J Hematol 2002; 76(Suppl 2):240-245
7. Murphy EL, Hanchard B, Figueroa JP, et al.: Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer 1989; 43:250-253
8. Watanabe T: HTLV-1-associated diseases. Int J Hematol 1997; 66:257-278
9. Yamada Y, Atogami S, Hasegawa H, et al.: Nationwide survey of adult T-cell leukemia/lymphoma (ATL) in Japan. Rinsho Ketsueki 2011; 52:1765-1771
10. Yamada Y, Tomonaga M, Fukuda H, et al.: A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 2001; 113:375-382
11. Matsuoka M, Jeang KT: Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 2007; 7:270-280
12. Hino S, Katamine S, Miyata H, et al.: Primary prevention of HTLV-I in Japan. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13(Suppl 1):S199-S203
13. Kinoshita K, Amagasaki T, Hino S, et al.: Milk-borne transmission of HTLV-I from carrier mothers to their children. Jpn J Cancer Res 1987; 78:674-680
14. Yamanouchi K, Kinoshita K, Moriuchi R, et al.: Oral transmission of human T-cell leukemia virus type-I into a common marmoset (Callithrix jacchus) as an experimental model for milk-borne transmission. Jpn J Cancer Res 1985; 76:481-487
15. Kinoshita K, Yamanouchi K, Ikeda S, et al.: Oral infection of a common marmoset with human T-cell leukemia virus type-I (HTLV-I) by inoculating fresh human milk of HTLV-I carrier mothers. Jpn J Cancer Res 1985; 76:1147-1153
16. Tajima K, Tominaga S, Suchi T, et al.: Epidemiological analysis of the distribution of antibody to adult T-cell leukemia-virus-associated antigen: possible horizontal transmission of adult T-cell leukemia virus. Gan 1982; 73:893-901
17. Murphy EL, Figueroa JP, Gibbs WN, et al.: Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 1989; 111:555-560
18. Okochi K, Sato H, Hinuma Y: A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang 1984; 46:245-253
19. Manns A, Wilks RJ, Murphy EL, et al.: A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer 1992; 51:886-891
20. Nagai M, Usuku K, Matsumoto W, et al.: Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998; 4:586-593
21. King KE, Shirey RS, Thoman SK, et al.: Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion 2004; 44:25-29
22. The Trial to Reduce Alloimmunization to Platelets Study Group: Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997; 337:1861-1869
23. Bowden RA, Slichter SJ, Sayers M, et al.: A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995; 86:3598-3603
24. Pennington J, Taylor GP, Sutherland J, et al.: Persistence of HTLV-I in blood components after leukocyte depletion. Blood 2002; 100:677-681
25. Hewitt PE, Davison K, Howell DR, et al.: Human T-lymphotropic virus lookback in NHS Blood and Transplant (England) reveals the efficacy of leukoreduction. Transfusion 2013; 53:2168-2175
26. Okochi K, Sato H: Transmission of adult T-cell leukemia virus (HTLV-I) through blood transfusion and its prevention. AIDS Res 1986; 2(Suppl 1):S157-S161
27. Hinuma Y, Nagata K, Hanaoka M, et al.: Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78:6476-6480
28. Matsumoto C, Mitsunaga S, Oguchi T, et al.: Detection of human T-cell leukemia virus type I (HTLV-I) provirus in an infected cell line and in peripheral mononuclear cells of blood donors by the nested double polymerase chain reaction method: comparison with HTLV-I antibody tests. J Virol 1990; 64:5290-5294
29. Seiki M, Hattori S, Hirayama Y, et al.: Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci USA 1983; 80:3618-3622
30. Houldsworth A, Metzner MM, Demaine A, et al.: CD81 sequence and susceptibility to hepatitis C infection. J Med Virol 2014; 86:162-168
31. Levy S, Todd SC, Maecker HT: CD81 (TAPA-1): A molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 1998; 16:89-109
32. Akino M, Yamamoto S, Saikawa S, et al.: Prestorage leukocyte reduction with in-line filtration system for whole blood (Sepacell Integra MAP): evaluation of system efficiency and blood products. Jpn J Transfus Med 2000; 46:521-531
33. Dzik WH: Leukoreduced blood components: laboratory and clinical aspects. In: Simon T, Dzik WN, Snyder EL, et al., (eds): Rossi's Principles of Transfusion Medicine, 3rd ed. Wiley-Blackwell, 2001:271-287
34. Sullivan MT, Williams AE, Fang CT, et al.: Transmission of human T-lymphotropic virus types I and II by blood transfusion. A retrospective study of recipients of blood components (1983 through 1988). Arch Intern Med 1991; 151:2043-2048
35. Morishima Y, Ohya K, Ueda R, et al.: Detection of adult T-cell leukemia virus (ATLV) bearing lymphocytes in concentrated red blood cells derived from ATL associated antibody (ATLA-Ab) positive donors. Vox Sang 1986; 50:212-215
36. Kleinman S, Swanson P, Allain JP, et al.: Transfusion transmission of human T-lymphotropic virus types I and II: serologic and polymerase chain reaction results in recipients identified through look-back investigations. Transfusion 1993; 33:14-18
37. Ando Y, Kakimoto K, Tanigawa T, et al.: Effect of freeze-thawing breast milk on vertical HTLV-I transmission from seropositive mothers to children. Jpn J Cancer Res 1989; 80:405-407
38. Ando Y, Nakano S, Saito K, et al.: Prevention of HTLV-I transmission through the breast milk by a freeze-thawing process. Jpn J Cancer Res 1986; 77:974-977
39. Mazda T: Centralized quality control inspections for blood bags and leukocyte reduction at the Japanese Red Cross Society. ISBT Sci Ser 2011; 6:404-407
40. Naito Y, Shiba M, Okazaki H, et al.: Investigation of residual leukocytes, microaggregates and cytokine levels in prestorage leukoreduced blood components [in Japanese]. Jpn J Transfus Cell Ther 2009; 55:287
41. Satake M, Taira R, Yugi H, et al.: Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion 2007; 47:1197-1205
42. Hewitt PE, Ijaz S, Brailsford SR, et al.: Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014; 384:1766-1773
43. Hollingsworth TD, Anderson RM: Fraser C HIV-1 transmission, by stage of infection. J Infect Dis 2008; 198:687-693
44. Khabbaz RF, Onorato IM, Cannon RO, et al.: Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med 1992; 326:375-380
45. Murphy EL, Lee TH, Chafets D, et al.: Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion. J Infect Dis 2004; 190:504-510
46. Hisada M, Miley WJ, Biggar RJ: Provirus load is lower in human T lymphotropic virus (HTLV)-II carriers than in HTLV-I carriers: a key difference in viral pathogenesis? J Infect Dis 2005; 191:1383-1385
47. Kannian P, Yin H, Doueiri R, et al.: Distinct transformation tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and HTLV-2 is the result of postinfection T cell clonal expansion. J Virol 2012; 86:3757-3766
48. Kataoka R, Takehara N, Iwahara Y, et al.: Transmission of HTLV-I by blood transfusion and its prevention by passive immunization in rabbits. Blood 1990; 76:1657-1661